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Although the original Minnesota multiphasic personality inventory (MMPI) showed promise in.the psychometric 
discrimination of patients with epileptic seizures and pseudoseizures, inconsistencies and relatively low rates of 
accuracy have been reported. The present study evaluated the restandardized MMP1-2 for its accuracy in 
discriminating patients with pseudoseizures in a population with intractable pilepsy. MMPI-2 profiles for 139 
consecutive adult inpatients (24 with pseudoseizures) were classified as a pseudoseizure pattern if they had (a) a T 
score on Scale 1 and/or 3 -> 65, (b) Scale 1 or 3 in the 2-point high code, and (c) if 1 or 3 was not the highest scale, 
it was -<6T from the highest scale. Compared to studies using the original MMPI, it was expected the MMPI-2 
would more accurately classify patients in each group. Preliminary analyses revealed pseudoseizure patients had a 
greater history of mental health interventions and were older when their seizure disorder began, relative to the 
epilepsy patients. A classification accuracy of 92% was found for pseudoseizures and 94% for epilepsy patients. For 
the pseudoseizure group, clinically meaningful MMPI-2 elevations followed a 3-1-2 pattern. No mean elevations 
above a T value of 65 were seen in the epilepsy group. 
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INTRODUCTION 
Pseudoseizures (or non-epileptic seizures) are 
paroxysmal alterations of behaviour which are 
non-epileptic in origin. Although their clinical 
manifestation may resemble seizures, charac- 
teristic electrographic and other ictal phenomena 
are missing ~'2. In addition no physiological cause 
can be readily demonstrated for pseudo- 
seizures 3'4. Prevalence estimates of pseudo- 
seizures range from 5 to 35% of patients thought 
to have epilepsy 5'6. Although accurate diagnosis 
of pseudoseizures can be difficult, it is crucial 
because such individuals may be treated as 
though they have epilepsy, often leading to 
inappropriate treatment 7, long delays before 
treating the presumed psychological problems 8,
and unnecessary health care expenses. 
At present, reliable diagnosis of pseudoseizures 
is complex and costly 3"4"~J°-13. Betts and Boden ~4 
note that despite sophisticated continuous EEG 
recording and even depth electrode studies, it 
"may still be impossible to decide what one is 
dealing with'. Psychological tests are potentially 
important adjuncts in diagnosing pseudo- 
seizures ~-'6'~5. The MMPI has been the most 
consistently-studied measure 6"~6"~7, but others 
such as the MCMI and the WPSI have oc- 
casionally appeared ila the literature 6"t8. The 
ability of psychological tests to discriminate 
pseudoseizures from epileptic seizures has been 
inconsistent. Using MMPI profile analyses, some 
reports have been unable to discriminate pseudo- 
seizure patients from genuine seizure 
patients tS'tg. In contrast, Wilkus et al 6 devised 
three classification rules based on MMPI profiles, 
and found pseudoseizure patients were correctly 
classified in 80-90% of cases. Those rules were 
based on elevations on scales 1 (hypochondriasis) 
and 3 (hysteria) in various configurations relative 
to other scales. However a replication study ~9 
found no MMPI differences between epileptic 
and non-epileptic groups. A more recent attempt 
to resolve these divergent results ~5 only seems to 
have further confused the picture. Among 
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pseudoseizure patients, scales 1, 2, 3 and 8 were 
elevated (T >70), but only scale 1 was higher 
relative to the epileptic group. Using the Wilkus 
et al 6 MMPI rules for their patients, accurate 
classification was only 61% for pseudoseizures 
and 80% for epileptic patients ~5. 
These findings suggest that the MMPI has 
promise in contributing to the diagnosis of 
pseudoseizures, but that further work is needed. 
Previous results may have been confusing due to 
inaccurate diagnosis of the criterion groups, 
leading to misclassification f patients. Moreover, 
the original MMPI may to an unknown degree 
have had measurement limitations within this 
population. We evaluated the possibility that the 
advent of the MMPI-2 into clinical practice would 
increase the accuracy with which pseudoseizure 
patients can be psychometrically distinguished 
from epilepsy patients. It was expected that the 
MMPI-2 would be an improvement over previous 
MMPI studies in terms of more accurate clas- 
sification of patients. We predicted it would be at 
least 85% accurate in identifying both pseudo- 
seizure patients and epilepsy patients. As well, 
compared to epilepsy patients, the pseudoseizure 
group was expected to show significantly higher 
elevations on the hysteria and hypochondriasis 
scales of the MMPI-2. 
METHOD 
Participants 
Patients were 139 consecutive adult (age-  > 18 
years) admissions to the Epilepsy Unit of 
University Hospital, a regional epilepsy centre 
within a tertiary care teaching hospital. The sole 
exception to this was one pseudoseizure patient 
who was a psychiatric admission to the same 
hospital, but who was well-known to the epilepsy 
service. Pertinent demographic data summarizing 
these patients are presented in Table 1. Subjects 
ranged in age from 18 to 57 years and had an 
overall mean education of 12.5 years. In the 
pseudoseizure group there were 13 females 
(54%) and 11 males (46%). In the epileptic 
seizure group there were 61 females (53%) and 54 
males (47%). Comparisons of these means 
revealed no statistically significant between-group 
gender differences. 
Diagnosis 
Patients were referrals for treatment of intrac- 
table seizures to a regional epilepsy service, a 
large component of which is an inpatient Epilepsy 
Unit which evaluates patients as candidates for 
epilepsy surgery. All underwent continuous EEG 
telemetry along with behavioural observation by 
medical and technical staff who were intensively 
trained regarding seizure phenomenology. When 
seizure activity was suspected, staff examined and 
recorded patients' responsiveness, memory, 
language, and behaviour. 
Pseudoseizures were diagnosed by a neuro- 
Iogist/epileptologist according to two criteria. 
First, paroxysmal behaviourai disturbances re- 
sembling seizures were accompanied by no 
change (and no epileptiform activity) in the 
on-going EEG recording on at least two occa- 
sions. Second, both the neurologist and the 
patient agreed that the spells designated as 
pseudoseizures represented a clinically meaning- 
ful problem in the patient's life. As is the case in 
other centres t L2~, our experience is that patients 
present with a combination of epilepsy and 
pseudoseizures. In our pseudoseizure group 13 
(54%) had a combination of pseudoseizures and 
epilepsy, while 11 (46%) had pseudoseizures 
only. 
Patients in the epilepsy group were diagnosed 
Table 1: Demographic haracteristics of pseudoseizure and epilepsy patients 
Pseudoseizures 
(n = 24 
Epilepsy t-value 
(n = 115) 
M (sd) M (sd) 
Age at investigation (yrs) 32.5 (11.4) 30.2 (9.5) ns 
Age at first seizure 23.6 (13.8) 14.5 (9.7) 2.7* 
Full scale IQ 95.1 (9.9) 98.9 (13.7) ns 
Years of education 12.3 (2.6) 12.6 (3.1) ns 
Psychiatric historyt 17 (71%) 36 (31%) 
* 1-tailed t-test; P = 0.01 
t Number of patients with history of psychiatric 
square (1 df )= 11.53. P = 0.0007). 
or psychological intervention (Chi 
MMPI-2 and pseudoseizures 
by observing characteristic ictal EEG changes 
with no electrographic or behavioural evidence of 
non-epileptic seizures. All were taking at least 
one antiepileptic drug with serum blood levels in 
the therapeutic range. In our sample, 104 (90%) 
had complex partial seizures as the primary 
diagnosis, 2 (2%) has simple partial seizures, and 
9 (8%) had generalized tonic-clonic seizures 
(including absence seizures) as the primary 
diagnosis. This is comparable to other studies 
such as Wilkus et a l  ~ where 23 of their 25 patients 
(92%) had complex partial seizures. 
All patients were administered a battery of 
neuropsychological tests as part of their clinical 
investigation. Subdural electrode recordings, 
MRI investigations and sodium amytal testing 
were conducted where clinically indicated. 
Measures 
MMPI-2 
The Minnesota multiphasic personality inven- 
tory-2 (MMPI-2) 2j is widely used to assess 
psychopathology. It is a restandardization and 
revision of the original MMPI with item content 
that is more contemporary and less ambiguous. 
Uniform T-scores were  derived from norms 
collected on a national census-matched sample of 
2600 men and women 2~. The MMPI-2 yields ten 
clinical scales measuring psychopathology, and 
also provides content scales. Only the clinical 
scales were analysed in this study. In addition, a 
pilot study in our centre indicated no male- 
female differences for MMPI-2 scores. For this 
reason scores for both sexes were combined, and 
Scale 5 (masculinity-feminity) was not reported. 
To complete the MMPI-2 the patient must have 
had a grade 6 English reading level and an IQ 
greater than 75 (assessed by a routine neuropsy- 
chological evaluation). 
Procedure 
Consecutive epilepsy unit admissions between 
October 1992 and May 1994 were classified by a 
neurologist into pseudoseizure and epilepsy 
groups. The accuracy of sorting MMPI-2 profiles 
as 'epilepsy' or 'pseudoseizure', according to the 
classification rule described 
determined. 
below, 
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was then 
RESULTS 
Demographic 
Table 1 summarizes relevant demographic data 
for the two groups. It reveals no statistically 
significant differences for age, IQ, and years of 
education. However, pseudoseizure patients were 
significantly older when their first seizure oc- 
curred (23.6 years vs. 14.5 years for epilepsy 
patients; P = 0.01). A significant difference with 
respect o psychiatric history also emerged: 71% 
of pseudoseizure patients had a history of 
psychiatric or psychological intervention, in con- 
trast to only 31% of epilepsy patients (Chi square 
(1 df) = 11.53, P = 0.0007). 
MMPI-2 group differences 
Figure 1 portrays profile elevations for the 
pseudoseizure and epilepsy groups. A multivari- 
ate analysis of variance (MANOVA) was con- 
ducted to test for an overall between-group 
effects, revealing a significant Hotellings F 
(12, 126)= 11.26 . (p -- 0.001). In evaluating 
differences between pseudoseizure patients and 
epilepsy patients on individual scales (sum- 
marized in Table 2), one-tailed t-tests indicated 
means for the pseudoseizure group were sig- 
nificantly higher for Scale 1 (hypochondriasis; 
P=0.0001),  Scale 2 (depression; P--0.001), 
Scale 3 (hysteria; P=0.0001),  Scale 4 (psycho- 
pathic deviate; P =0.03), and Scale 10 (social 
introversion/extroversion; P = 0.05). 
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Fig. ] : Mean MMPI-2 T-scores by group. - - - -. Epileptic 
seizures; --, pseudoseizures. L, Lie scale; F, F scale; K, K 
scale; Hs, hypochondriasis; D, depression; Hy, hysteria; Pd, 
psychopathic deviate; Pa, paranoia; Pt, psychasthenia; Sc, 
schizophrenia; Ma, mania; Si, social introversion. 
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Table 2:MMPI-2 T scores for scales by groups 
MMPI-2 Scale Pseudoseizures Epileptic seizures 
M sd M sd 
L 58.7 11.2 54.8 10.9 
F 55.6 9.9 56.4 11.6 
K 54.2 9.8 49.0 11.2 
Hs 76.9 7.2 55.0 9.6 
D 68.3 11.9 59.5 11.4 
Hy 76.1 10.9 52.9 10.0 
Pd 57.1 9.1 51.8 10.9 
Pa 57.3 10.6 54.2 14.2 
Pt 61.7 12.4 58.8 11.4 
Sc 64.1 8.0 60.0 12.5 
Ma 55.6 9.8 54.8 9.6 
Si 49.3 10.4 54.0 10.6 
L, Lie scale: F, F scale: K, K scale: Hs, hypochondriasis: D, depression: 
Hy, hysteria: Pd, psychopathic deviate: Pa. paranoia: Pt, psychasthenia; 
Sc, schizophrenia: Ma, mania: Si, social introversion. 
Clinically meaningful elevations 
As can be seen in Fig. 1, in the pseudoseizure 
group scales 1-3-2 (in order of highest elevation) 
were elevated to a point of clinical significance 
(i.e. T > 65). There were no clinically significant 
elevations for the epilepsy patient group. 
As is presented in Table 3, the MMPI-2 
correctly identified pseudoseizure patients in 22 
of 24 cases (92%) and was in error in the 
remaining two patients (6%). It correctly iden- 
tified 94% of epilepsy seizure patients (108 of 115 
patients), and was in error in the remaining seven 
cases (6%). 
MMPI-2 classification accuracy DISCUSSION 
The next step was to assess the percentage of 
cases where the MMPI-2 accurately identified 
pseudoseizures and epilepsy patients. To ac- 
complish this, a classification rule was deter- 
mined. Previous tudies 6 used complex multi-step 
rules; our MMPI-2 rule was generated with power 
and simplicity as criteria, utilizing the significant 
between-group differences described above. A 
pseudoseizure profile met each of the following 
criteria: (a) a Tscore on Scale 1 and/or 3 -> 65, (b) 
Scale 1 or 3 appearing in the 2-point high code, 
and (c) if 1 or 3 was not the highest scale, it must 
be -<6T from the highest scale. For example, a 
2-1 profile, where both scales 2 and 1 were 
elevated beyond a T of 65, was classified as 
'pseudoseizure' if Scale 1 was no more than 6T 
less than Scale 2. 
It has long been recognized that psychological 
tests make a major contribution to the diagnosis 
and management of epilepsy a3. The original 
version of the MMPI showed great promise in its 
discrimination between patients with epilepsy and 
those with pseudoseizures 6 but inconsistencies a
well as replication failures had also been 
reported 19. To our knowledge the present study 
represents the first published evaluation of the 
MMPI-2 in the context of identification of 
pseudoseizures. We found the MMPI-2 to have a 
high degree of accuracy in classifying both 
pseudoseizure patients (92%) and patients with 
epileptic seizures (94%). Only one unpublished 
report 24 has evaluated the MMPI-2 in this 
fashion. In a small sample (22 patients with 
psychogenic seizures and 17 with epileptic sei- 
Table 3: Epilepsy patients and pseudoseizure patients correctly classified by 
MMPI-2 
Original diagnosis of 
Pseudoseizures Epileptic seizures Total 
MMPI-2 Classified as: 
Pseudoseizures 22 (92%) 7 (6%) • 29 
Epileptic seizures 2 (9%) 108 (94%) 110 
Total 24 115 139 
MMPI-2 and pseudoseizures 39 
zures), Warner et a124 found the MMPI-2 cor- 
rectly classified 77% of pseudoseizure patients 
and 82% of epileptic patients using the Wilkus et 
al 6 rules. The present study represents a stronger, 
more stringent est of the discriminative ability of 
the re-standardized MMPI-2, with its more 
extensive norms and updating of certain items 22, 
in the detection of pseudoseizure patients. Our 
results also suggest hat compared to the MMPI, 
the MMPI-2 offers somewhat improved predic- 
tive accuracy. Wilkus et al 6 correctly classified 
80-90% of their 15 pseudoseizure patients using 
their MMPI rules. With a larger sample and an 
easily-applied MMPI-2 classification rule we 
realized a 92% accuracy rate. 
The Wilkus et al 6 and Warner et a124 pseudo- 
seizure groups were composed of individuals who 
only had pseudoseizures: patients were excluded 
if they also had epileptic seizures. By including 
patients with both pseudoseizures and epileptic 
seizures we believed we were evaluating a sample 
more representative of the neurologist's practice. 
This is because the typical diagnostic question is 
whether a given patient has pseudoseizures, even 
though they may also have epilepsy. In the 
presence of some epileptiform EEG activity, the 
clinician may suspect pseudoseizures because of 
factors such as an atypical clinical presentation, 
absence of an EEG correlate during the seizure 
symptoms, or a significant psychiatric history. In 
such cases, where the differentiation is not 
between 'pure epilepsy' and 'pure pseudo- 
seizures' but rather a mixture of the two, the 
strength of the present study lies in permitting 
increased confidence in the diagnosis of pseudo- 
seizures. The MMPI-2 by itself cannot diagnose 
such a disorder. Instead, our data suggest it can 
be a clinically useful adjunct, along with other 
salient signs, in the confident diagnosis of this 
problem. 
Consistent with prior MMPI studies 6"15J6"24, the 
typical MMPI-2 profile in the pseudoseizure 
group was a conversion or somatoform pattern 
with Scales 1 and 3 highest and 2 also elevated. 
Although conversion and somatoform disorders 
were the modal profiles (19 of 24), several 
pseudoseizure patients had dysthymic and de- 
pressive MMPI-2 patterns and one had another 
personality disorder. We therefore do not argue 
that pseudoseizure patients constitute a homo- 
geneous group. This diversity has also been 
reported by other authors  2J4`t7. 
Diagnosis in our cases was based on clinical 
suspicion and scalp-recorded EEG telemetry. 
Although some might argue that only invasive 
recordings with depth or subdural electrodes can 
provide a definitive diagnosis of pseudoseizures, 
the advisability of utilizing such practices in every 
patient is questionable when the clinician already 
has a reasonable suspicion the patient has 
pseudoseizures. Further, all of our pseudoseizure 
patients had reductions or eliminations of their 
anticonvulsant medication with no accompanying 
worsening of their disorder. 
Much work remains before a clearer under- 
standing of the causes of pseudoseizures i
obtained. The present study can be added to a 
growing literature pointing to the emotional and 
psychological correlates of this problem. In 
particular, our data support the MMPI-2 as a 
reasonably accurate, inexpensive and non- 
invasive clinical adjunct to the diagnosis of 
pseudoseizures. 
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